Translate this page into:
Imaging challenges in Charcot’s neuroarthropathy and diabetic foot: Distinguishing infective and non-infective conditions
-
Received: ,
Accepted: ,
How to cite this article: Chandra AA, Choudhury SR, Chandra A, Mehta CP, Botchu R, Agarwal A. Imaging challenges in Charcot’s neuroarthropathy and diabetic foot: Distinguishing infective and non-infective conditions. Indian J Musculoskelet Radiol. 2026;8:16-29. doi: 10.25259/IJMSR_31_2025
Abstract
Charcot neuroarthropathy (CN) is a polyneuropathy-based inflammatory pedal disease. It is most commonly reported in patients with diabetes mellitus, and in spite of dating back to the 1800s, its exact pathophysiology, diagnosis, and treatment remain under discussion. The term “diabetic foot” occurs in individuals who have a combination of peripheral neuropathy, peripheral vascular disease, and immunopathy as a result of longstanding poor glycemic control, leading to CN, ulcerations, and also infection and diabetic foot osteomyelitis (DFO) can complicate the disease even further. It is imperative to make a timely diagnosis of DFO as infection will need aggressive antimicrobial and often surgical management, and a delay in diagnosis can lead to higher-level amputation due to ascending infection and systemic complications such as sepsis and multiorgan failure. Conversely, for uncomplicated CN, the management is primarily offloading and immobilization with stricter glycemic control. The purpose of this review is to elaborate on the imaging of Charcot’s foot and to differentiate between uninfected CN and DFO for optimal clinical and surgical management.
Keywords
Charcot foot
Diabetic foot osteomyelitis
Diabetic foot
Neuroarthropathy
GRAPHICAL ABSTRACT

INTRODUCTION
Jean-Martin Charcot and Charles Féré reported fracture dislocations of the foot in cases of tabes dorsalis in November 1883 with one of the presented cases dating 2 years earlier in 1881. Herbert William Page, a surgeon from London, is credited as the first person to describe this condition, having presented the case at an international congress in 1881.[1]
Charcot neuroarthropathy (CN) is described as a polyneuropathy-based inflammatory pedal disease relevant to a variety of conditions – diabetes mellitus, spinal cord and peripheral nerve injuries, cerebral palsy, alcoholic peripheral neuropathy, and Charcot-Marie-Tooth disease, most common in long-standing diabetics (~10 years).[2] The incidence of Charcot arthropathy is increasing, at least in part due to better diagnosis with newer imaging modalities, decreased hospitalization, fewer amputa tions, and early mobilization in patients with diabetic foot ulcers.[3]
Pathogenesis and causes of Charcot’s neuroarthropathy
There are two main theories proposed to explain the pathogenesis of Charcot arthropathy – neurotraumatic and neurovascular [Figure 1]. In the neurotraumatic theory, the scientists – Virchow and Volkman – suggest that due to hypoesthesia, the foot is susceptible to repeated and/or acute trauma. The absence of pain and thus continued weight bearing worsens the injury, resulting in fractures and deformities.[4] Mitchell and Charcot proposed the neurovascular theory which is based on the hypotheses that an increased blood supply to bone through arteriovenous shunting secondary to autoimmune dysfunction eventually leads to bone resorption and mechanical weakening, ultimately resulting in fractures and deformity.[4] Other additional factors like osteopenia in type I diabetes with low body mass index[5] predispose to significant injuries from trivial trauma. Non-enzymatic glycation of Achilles may contribute to Achilles shortening and thus, foot deformity.[6] Recent evidence suggests that patients with Charcot arthropathy are predisposed to have a higher pro-inflammatory response.[7] This may explain the predilection for joints held together with ligamen ts - Lisfranc and Chopart joints.[4]

- Pictorial representation of the two main proposed theories for the development of neuroarthropathy.
While diabetes is the leading cause of CN by far, there are many other conditions which predispose to polyneuropathy. Other notable causes are:
Alcoholic neuropathy
Leprosy (Hansen’s disease)
Syphilis (tabes dorsalis)
Syringomyelia (especially upper-limb joints, but can involve the foot if the lumbosacral cord affected)
Spinal cord injury
Congenital insensitivity to pain
Peripheral nerve injuries (trauma, surgery, advanced entrapment neuropathies)
Rarer causes like - Folic acid deficiency neuropathy, multiple sclerosis, post-polio residual paralysis, Amyloid neuropathy, meningomyelocele/spina bifida.
Clinical conundrum in the diabetic patient: CN and the diabetic foot
Long-standing diabetes predisposes to Charcot foot due to peripheral neuropathy (loss of protective sensation, muscle imbalance, autonomic hyperemia) and metabolic bone weakening, which together lead to repetitive unperceived trauma, bone resorption, joint destruction, and progressive foot deformity. In addition to an increased risk of CN, diabetic individuals are prone to developing foot ulcers which are in fact more common presenting features, often leading to severe complications.[8] More than 50% of diabetic individuals with foot ulcers present with clinical signs of infection at the initial contact, and as many as 20–60% may have underlying osteomyelitis - diabetic foot osteomyelitis (DFO).[9] Bone infections develop due to direct contiguous spread from overlying soft tissue infection, increasing morbidity [Figure 2].[9]

- Pictorial flow chart of the development of diabetic foot osteomyelitis in the presence of uncontrolled hyperglycemia, worsened by coexisting neuropathy, microangiopathy, and immune dysfunction.
The critical need for accurate differentiation
CN and DFO both have clinically overlapping features with significantly different treatment measures, necessitating differentiation between the two. CN represents a sterile, neuropathy-driven inflammatory and destructive process of the joints, whereas DFO is an infective condition involving the bones and joints, usually arising from a cutaneous infection or an ulcer or sinus tract. CN is managed primarily with immobilization and offloading (such as total contact casting or orthotic walkers), along with strict glycemic control and corrective surgery only in severe deformity, whereas DFO requires prolonged culture-directed antibiotics, surgical debridement or limited amputation if needed, plus wound care, offloading, and revascularization when ischemia is present.
REVIEW OF CURRENT LITERATURE
Most previous published work on CN and DFO emphasizes on the role of multimodality imaging and multidisciplinary discussions. Conventional plain radiographs were the very first imaging modality used for CN, long before magnetic resonance imaging (MRI) or advanced nuclear medicine became available. For decades, they were the mainstay of investigation and clinicians heavily relied on them to establish the diagnosis and monitor progression. The pitfall of radiographs was that they were insensitive to detecting early disease, and in many cases could not reliably differentiate CN versus DFO. Early CN may present with no radiographic signs and here the role of MRI is crucial for prompt detection.[10] The role of MRI in CN and DFO is today well established, and evidence regarding its utility to detect infections in the diabetic foot dates back to 1996, when a paper by Croll et al. demonstrated high sensitivity, specificity, and accuracy of MRI.[11] In the early 2000s, MRI became more widely used for diabetic foot because it allowed earlier diagnosis of Charcot changes and differentiation from infection before radiographs turned abnormal.[12] The use of nuclear medicine has also greatly evolved in the decades. In the older days, a three-phase bone scintigraphy was performed which showed tracer uptake increase in patients with peripheral neuropathy even before the onset of neuro-arthropathy.[13] There is however low anatomic resolution of conventional planar imaging, and hybrid single photon emission computed tomography/computed tomography (SPECT/CT) combines both functional and structural imaging to allow accurate diagnosis.[14] The CT counterpart of the investigation is used to diagnose microtrabecular fractures or other early and subtle bony abnormalities; the SPECT component determines the blood flow and tracer uptake. The earliest published work on the use of Bone Scintigraphy and Indium- 111 Leukocyte Scans in Neuropathic Foot Disease dates back to 1988.[15] In the 90s, Technetium-99m-hexamethylpropyleneamine oxime scan (HMPAO) labeled white blood cells (WBC) started to show promise for scintigraphy in infections and eventually became very important for the complex and equivocal cases of DFO.[16] Dual energy CT (DECT) with virtual non-calcium postprocessing has also shown good sensitivity and specificity for bone marrow edema detection.[17]
CLINICAL FEATURES
Charcot’s neuroarthropathy
CN can present either acutely or as a chronic condition with both the phases often overlapping [Figure 3]. Acute CN typically presents with the sudden onset of swelling, erythema, warmth, and edema of the foot or ankle, often following trivial trauma. Despite the striking inflammatory appearance, patients usually report little or no pain due to underlying neuropathy. The marked local hyperemia and temperature rise frequently mimic cellulitis, deep vein thrombosis, or gout, leading to misdiagnosis in the early stage. In contrast, chronic CN is characterized by longstanding, progressive deformity of the foot or ankle, most classically the development of a “rocker-bottom” foot due to collapse of the midfoot arch. These patients generally remain painless but demonstrate joint instability, malalignment, and abnormal weight-bearing with varus or valgus deformities. Chronic pressure overload results in recurrent plantar ulcers, callus formation, and a predisposition to secondary infections, which further complicate the clinical picture.[18]

- Comparative analysis of clinical features of Charcot neuroarthropathy and osteomyelitis. CN: Charcot neuroarthropathy, OM: Osteomyelitis, CRP: C-Reactive protein, ESR: Erythrocyte sedimentation rate, and WBC: White Blood Cell count, WB: Weight-bearing, DVT: Deep vein thrombosis, d/d: Differential diagnoses.
DFO
DFO most often arises as a complication of long-standing diabetic foot ulcers, especially those over pressure points such as the metatarsal heads, hallux, or heel. Clinically, patients present with a chronic, non-healing ulcer that probes to bone (probe-to-bone test) often accompanied by local pain, swelling, erythema, and purulent discharge. The overlying skin is usually ulcerated or broken, distinguishing it from Charcot arthropathy, which may occur with intact skin. Systemic features such as fever, leukocytosis, or elevated inflammatory markers may be present, though many patients remain relatively asymptomatic because of peripheral neuropathy. If untreated, it can lead to extensive bone destruction, abscess formation, and ultimately amputation. DFO is more likely to be present with an ulcer more than 3 mm in depth and 2 cm2 in area.[19]
Acute CN: Radiologically silent stage of disease
Acute CN presents with clinically active inflammation corresponding to stages 0, 1, and 2 of the modified Eichenholtz classification [Figure 4].[20] Stage 0 which is negative on radiographs represents an early stage of CN. MRI is useful in early stages to identify bone marrow edema and changes in the Lisfranc ligament which eventually lead to midfoot collapse.[21] Stage 3 of Eichenholtz classification represents the chronic, coalescent stage of inactivity and residual deformity [Figure 5].

- Modified Eichenholtz classification correlating clinical findings with radiograph.

- Clinical stages of Charcot neuroarthropathy.
The most commonly used anatomical classification is described by Sanders and Frykberg - Pattern 1 involves the phalanges, interphalangeal, and the metatarsophalangeal joints; pattern 2 involves the tarsometatarsal (TMT); pattern 3 involves the cuneonavicular, talonavicular, and calcaneocuboid articulations; pattern 4 involves the talocrural joint; and pattern 5 involves the posterior calcaneum. Clinically pattern 2 followed by 3 is the most common [Figure 6].[22]

- Pictorial representation of the 5 zones of involvement of the foot in neuroarthropathy as described by Sanders and Frykberg.
MULTIMODALITY IMAGING FINDINGS
Multimodality imaging is utilized to assess CN and rule out associated infection in cases of DFO.[23] Imaging plays a crucial role in early detection, differentiating it from osteomyelitis, assessing the extent of bone and joint involvement, monitoring disease stage (Eichenholtz), and guiding both conservative and surgical management.
Conventional radiographs
Radiographs are the first choice of investigation of CN with demineralization being the earliest marker of neuropathic osteoarthropathy and flattening of the metatarsal head favors diabetic neuroarthropathy.[21] Lack of soft tissue involvement in the presence of midfoot subchondral or periarticular changes with polyarticular distribution indicates diabetic neuroarthropathy.[24]
Acute and chronic CN
Weight-bearing serial radiographs are the mainstay of radiographic evaluation of CN to rule out progressive foot collapse. Typical measurements acquired on radiographs include[10] Meary’s angle [Figure 7], cuboid height [Figure 8], calcaneal pitch [Figure 9], and oblique radiographs add value in assessing the 3rd–5th TMT joints [Figure 10].

- Meary’s angle: Angle (white) between the line originating from the center of the body of the talus (thin red line), bisecting the talar neck and head, and the line through the longitudinal axis of the 1st metatarsal (thick red line) with 0° being normal.

- Cuboid height: Distance perpendicular from the plantar cuboid (yellow double headed arrow) to a line drawn from the plantar surface of the calcaneal tuberosity to the plantar aspect of the 5th metatarsal head (red line). 2.2 cm above the line is the mean normal value.

- Calcaneal pitch: Angle (white) between a line extending from the plantar aspect of the calcaneus to the plantar surface of the 5th metatarsal head (red line) and the line extending from the most plantar portion of the calcaneal tuberosity to the most plantar portion of the anterior calcaneus (green line) with angle between 20 and 30° being normal.

- Oblique radiographs demonstrating the 3rd to 5th magnetic resonance imaging tarso-metatarsal joints (white encircled).
In the early stage of CN (Stage 0 modified Eichenholtz), the X-ray findings may be normal or equivocal. In stage 1 (fragmentation and destruction), there is osteopenia, fragmentation of the subchondral bone, and small periarticular debris which may be distinguishable. In stage 2 (coalescence), the osteopenia may also be accompanied by early sclerosis of the bone ends, absorption of the fine debris and larger bone fragments, as well as joint subluxation and dislocation. In stage 3 (reconstruction/consolidation phase), the most marked findings will be the residual deformity (ankylosis/pseudoarthrosis) and joint remodeling. Radiographic features of acute CN include soft tissue edema, juxta-articular osteopenia, periosteal reaction and may have a background of chronic CN in the form of fracture-dislocations and joint destruction[24] [Figure 11]. Follow-up radiographs are essential to assess for progressive foot collapse/deformity due to involvement of the TMT joints, resulting in collapse of the load-bearing longitudinal arch and cuboid, resulting in the “rocker bottom foot.” Chronic stage fits into the rule of “6 D’s” – joint distention, destruction, dislocation, disorganization, debris, and increased bone density. Forefoot “Pencil and cup”/“sucked candy” appearance is seen due to tapering of the metatarsal and phalangeal diaphysis [Figure 11].[3]

- Sequential radiographs and magnetic resonance imaging (MRI) of a 50-year-old diabetic male with acute on chronic Charcot’s neuroarthropathy. (a) Oblique, anteroposterior, and lateral radiographs demonstrating subchondral cystic change at the 1st and 2nd tarsometatarsal (TMT) joints (yellow arrows) with healed metatarsal fracture (black arrow) and evidence of the acute phase of neuroarthropathy in the form of diffuse periarticular osteopenia and subcutaneous soft tissue edema (green arrow in a). Note the cuboid height (red double arrowhead). (b) Follow-up radiograph after 1 year demonstrates progressive foot collapse (red line), worsening of TMT joint arthropathy with a sucked candy appearance at the metatarsophalangeal and TMT joints (yellow arrows). New bone formation on the dorsal aspect of the TMT joints (white arrow). (c) Corresponding MRI image shows features of acute and chronic neuroarthropathy - joint fluid with subchondral edema and cysts (yellow arrows), osteitis with corresponding hazy and reticular T1 low signal and preserved cortex suggesting edema, without osteomyelitis (blue arrows), heterogeneous Lisfranc ligament (red arrow), and new bone formation at the TMT joint (white arrow).
Radiographic signs of osteomyelitis
Osteomyelitis in its early stages has only demineralization, periosteal reaction, cortical destruction, and marrow lucency [Figure 12] which becomes visible after 2–3 weeks, necessitating the utilization of advanced imaging for early identification of osteomyelitis.[8] New bone formation, bone sclerosis, sequestrum, involucrum, and cloacae can be seen in chronic cases.

- Radiographs of a diabetic 48-year-old with pus discharge from the tip of the second toe. (a) Lateral, oblique, and AP radiographs demonstrate osteolysis of the distal phalanx of the second digit, with tiny bony fragments, soft tissue edema, and overlying skin ulceration (red circle). Background changes of neuroarthropathy in the form of tarsometatarsal joint arthropathy with subchondral osteopenia and subcutaneous soft tissue edema can be seen (white circle) Note the reduced calcaneal pitch in the lateral foot radiograph (red line and white diamond). (b) MR images reveal moderate edema in the tip of the distal phalanx with loss of cortex at the tip (red arrows) representing Ghost sign on T1-weighted images (top left), suggestive of osteomyelitis. Background severe tarsometatarsal arthropathy characterized by subchondral edema, cystic changes, new bone formation, and overlying subcutaneous edema (white arrows).
CT
Three-dimensional and multiplanar reformatted CT images are useful for assessing the altered bony anatomy and joint alignment in pre-surgical planning in chronic CN cases. CT can detect micro-trabecular fractures and early bony deformities in the acute phase. Bone destruction in osteomyelitis, sequestrum, and cloacae can also be identified on CT in chronic cases. Ancillary findings of diabetic neuropathy include diffuse fatty infiltration in intrinsic muscles and luminal calcification in the visualized vessels [Figure 13]. By exploiting material decomposition, DECT can help detect and quantify urate crystals, bone marrow edema, and subtle differences in bone composition. In CN, DECT may demonstrate subchondral cysts, fragmentation, and new bone formation without significant bone marrow edema, whereas in osteomyelitis, it can highlight areas of medullary bone marrow edema and cortical destruction adjacent to an ulcer or sinus tract.[17,25] Emerging evidence suggests that DECT has moderate sensitivity and high specificity for bone marrow edema detection, potentially approaching MRI in diagnostic performance, and may be particularly useful in patients with MRI contraindications such as severe renal impairment, metallic hardware, or claustrophobia.

- (a-b) Computed tomography and magnetic resonance imaging (CT and MRI) of a diabetic 60-year-old male with a history of pus discharge from the dorsum of midfoot. (a) Reformatted CT images demonstrate osteolysis in the shaft of the 3rd metatarsal with periosteal elevation and complete effacement of surrounding fat (white circle and arrow). Ancillary feature of microangiopathy in the form of vessel wall calcification (red arrow) is seen. (b) Axial and coronal short tau inversion recovery MRI images demonstrate an ill-defined collection around the metatarsal shaft (blue arrows) with subperiosteal fluid (white arrows), suggesting osteomyelitis. Mild subchondral edema can be seen in the cuneiforms in the midfoot.
Magnetic resonance imaging
MRI plays a central role in the evaluation of diabetic foot complications, particularly in differentiating CN from DFO. In the acute phase of CN, MRI is highly sensitive for detecting early changes such as bone marrow edema, microtrabecular fractures, and subchondral changes, which may not be visible on radiographs.[26] MRI also demonstrates associated soft tissue edema and joint effusions, allowing for early diagnosis and intervention before significant deformity develops. Early identification of disruption of Lisfranc ligament can help in the management and prevention of longitudinal arch in early stages of the disease.[27] In chronic CN, MRI helps delineate the extent of bony fragmentation, sclerosis, disorganization, and deformity, although marrow edema may be less pronounced.
MRI planning and protocol
A large field-of-view is utilized to allow complete visualization of the entire foot when assessing for diabetic foot. Routine sequences include multiplanar T1-weighted, STIR, and T2-weighted images with additional contrast media application for patients with suspected infection/osteomyelitis if needed. Smaller field of view is added when infection at the distal toes is suspected.[28]
Findings in early CN
Early stages of acute CN present with only soft tissue swelling. Joint effusions and subchondral bone marrow edema of involved joints are commonly seen in acute CN. Bone marrow edema is seen as reticular low signal on T1 and high signal on T2-weighted images and the entire medullary bone can be involved [Figure 11].[29] In post-contrast studies, enhancement is typically subchondral. Caution must be exercised when assessing cases with acute fractures since the presence of a fracture can alter the marrow signal.
Findings in established/Chronic CN
In the chronic stage, edema and enhancement become less pronounced. Well-marginated subchondral cysts, bone proliferation, and debris or intra-articular bodies can be seen. Overall, there is a decrease in signal intensity, consistent with osteosclerosis. Joint deformity, subluxations, and dislocations can also be identified.[18] Soft tissue findings of neuroarthropathy are important ancillary features which come to the rescue in atypical and overlapping cases. These findings include callus formation at sites of weight-bearing with the exact location variable due to the varied biomechanics of each foot, commonly being at the base of cuboid in patients with established neuropathy.[30] These areas of callus formation appear as T1 hypointense and T2 iso-hyperintense areas in the subcutaneous heel fat with overlying skin thickening [Figure 14].

- (a-c) Soft tissue ancillary findings in neuroarthropathy include callus formation at sites of weight-bearing and the exact location varies due to the varied biomechanics of each foot. Note: callus formation in the form of low signal on all sequences at sites of chronic friction (white arrows in coronal T1 weighted image of the forefoot in a, coronal PD image of the forefoot in b and axial T1 weighted image of the forefoot in c).
Upon ulceration, these areas begin to show T2 hyperintensity and skin irregularity with peripheral post contrast enhancement. Once infected, these can propagate infection to the underlying bone and joint. Ancillary findings of neuropathy also include diffuse atrophy of the intrinsic muscles of the foot, appearing as T1 hyperintense fat replacing the muscle fibers [Figure 15]. Diffuse subcutaneous fat edema is another finding in acute neuroarthropathy.

- Multiplanar magnetic resonance imaging of a 32-year-old female with Charcot–Mary–Tooth disease presenting with a draining sinus on the plantar aspect of the 4th metatarsophalangeal joint. Sagittal T1 and short tau inversion recovery images (upper row) demonstrate skin ulceration (white arrows in both lower and upper row), joint effusion (red arrows in both lower and upper row), and osteitis (blue arrows) characterized by hazy and reticular low T1 signal with interspersed areas of preserved marrow fat and high short tau inversion recovery signal. Note T1 ghost sign characterized by blurring of the plantar cortex of the metatarsal head is highly suspicious for osteomyelitis (pink arrows). In the lower row, the first image demonstrates diffuse fatty infiltration in intrinsic muscles (yellow arrow) consistent with denervation-related changes. Enhancement of reactive osteitis can be seen in the last images (blue arrow).
Findings in DFO
Osteomyelitis on MRI is based on abnormal marrow signal with hypointensity on T1-weighted images and hyperintense signal on fluid-sensitive images with the T1 images being more predictive of true marrow infiltration [Figure 12]. Confluent pattern of hypointensity completely replacing the marrow fat favors osteomyelitis, while hazy and reticular pattern with interspersed spared marrow fat is more commonly seen in reactive edema or osteitis.[26,31] Since DFO occurs most commonly due to contiguous spread of infection, adjacent soft tissue changes such as edema, ulcers, and sinus tracts should be closely looked for. These predominate in the forefoot, including under the heads of the first and fifth metatarsal, first phalanx, and in the hindfoot at the posterior plantar calcaneus. Subperiosteal hyperintensity (indicative of fluid or pus) is also a strong predictor of osteomyelitis [Figure 13]. Matching areas of T1 and T2 hypointensity raise suspicion of chronic or sclerosing osteomyelitis which are low-grade chronic processes of osteonecrosis, osteosclerosis and are sharply delineated from the normal marrow. The presence of T2 hyperintense patches may represent granulation tissue. Such equivocal cases warrant close follow-up for superimposed infection, true marrow edema, enhancement, and erosions.[26]
Ghost sign has also been described in which bones with active infection disappear on T1-weighted images and reappear on T2-weighted images [Figure 16]. Contrary to this, bones destroyed by neuroarthropathy will remain the same on all pulsed sequences.[32]

- An example of T1 ghost sign in which bones with active infection disappear on T1-weighted images and reappear on T2-weighted images (red arrows). Note the adjacent collection (yellow arrow) and background changes of subchondral edema at the tarsometatarsal joint (white circle) in this patient with Charcot neuroarthropathy with osteomyelitis.
DFO is also complicated by septic arthritis which is characterized by bony erosions, joint effusion, chondral destruction, thickened and enhancing synovium with pericapsular edema. Often, a communicating sinus tract is seen and joints adjacent to the affected joint may show reactive marrow edema. Edema extending into the subchondral bone with corresponding T1 hypointensity suggests associated osteomyelitis [Figure 15].[26]
Role of diffusion-weighted MRI
Diffusion-weighted imaging is an MRI technique which evaluates the motion of water molecular and biological tissues and is used widely for the characterization and identification of lesions. With respect to the evaluation of a neuropathic versus infected foot, diffusion-weighted image can help in differentiation by identifying areas of abscess formation and osteomyelitis. To acquire diffusion-weighted images, at least two b-values are required with the lowest being 50–200 s/mm2 and the highest being 800–900 s/mm2. These are chosen to balance between field inhomogeneity and maintain a certain degree of signal intensity.[33] In the presence of diffusion restriction, a collection is favored to represent infection, debris, pus, or inflammatory cells. Within soft tissues, these are likely to represent abscesses, infectious myositis, septic synovitis, or tenosynovitis. T2 shine-through effect is seen when there is high signal on both diffusion-weighted images and corresponding apparent diffusion coefficient (ADC) maps and these should be interpreted with caution. This effect is often seen in conditions such as soft tissue edema, muscle edema, and synovial cysts within the bone. This effect is seen in the context of osteomyelitis or trabecular contusion. A low signal on diffusion-weighted imaging with high signal on ADC map is seen in the context of free movement of the waters such as increased uptake of synovial cysts, subcutaneous synovitis, and subchondral cysts. A regular appearance of normal bone marrow and normal soft tissue is a low signal on both diffusion-weighted imaging and its corresponding ADC maps. The ghost sign of ADC is considered to be as specific and more sensitive than the ghost sign on T1W imaging for the identification of osteomyelitis. It is described as the disappearance of black bone on ADC map and appearance of hyperintensity due to diffusion restriction.[34]
Role of chemical shift imaging
Chemical shift imaging/Dixon imaging is also being used for better delineation of bony cortical outlines and characterization of edema patterns. Bland, transudative edema shows nulling of signal on out-of-phase images as compared to their in-phase counterparts, contrasting with infected, exudative edema of osteomyelitis.[35]
In diagnosing osteomyelitis, MRI has a sensitivity of 90% but there are certain conditions which warrant a bone biopsy for optimal patient management. Histopathological analysis remains the gold standard and biopsy can be performed either blind, in cases with actively draining sinuses’ or under image guidance. Conditions which require tissue sampling include cases where there is a high risk of osteomyelitis caused by an antibiotic-resistant organism, in cases with progressive bony deterioration or persistently elevated inflammatory markers and in patients in whom a surgical intervention with metalware insertion is being planned.[18]
NUCLEAR IMAGING
Nuclear imaging plays a crucial adjunctive role in the evaluation of the diabetic foot and CN, particularly when conventional imaging and MRI are inconclusive. In the diabetic foot, the primary challenge lies in differentiating between soft tissue infection, osteomyelitis, and sterile neuropathic changes. Three-phase bone scintigraphy with Technetium 99m-methyl diphosphonate is sensitive but non-specific, often yielding positive results in degenerative disease, fractures, and Charcot joints. Labelled leukocyte scintigraphy (In-111 or Tc-99m HMPAO WBC), particularly when combined with marrow scintigraphy or hybrid SPECT/CT, offers higher specificity and is recommended by b the European Association of Nuclear Medicine[36] for suspected osteomyelitis in diabetic foot, especially when MRI is equivocal or contraindicated. Fluorodeoxyglucose-positron emission tomography (FDG-PET)/CT has shown high diagnostic accuracy for diabetic foot infections and is recognized in recent guidelines as a valuable alternative, particularly in cases with previous surgery or hardware, or when systemic disease assessment is needed.[37] Guidelines recommend WBC scintigraphy with SPECT/CT or dual-tracer WBC and marrow imaging as the most reliable methods to differentiate active Charcot from superimposed infection. FDG-PET/CT may also assist in this setting, with diffuse, less intense uptake typical of CN, in contrast to the focal, intense uptake seen in osteomyelitis.
Management and diagnostic algorithm
The management strategies for CN and DFO differ fundamentally due to their distinct underlying pathophysiology. In CN, the primary goal is to halt inflammation and prevent further mechanical destruction through early and aggressive off-loading and immobilization, typically using a total contact cast or orthotic walker. In general, strict immobilization is observed until the acute phase subsides, followed by gradual mobilization and use of orthopedic shoes and braces. Pharmacologic agents such as anti-resorptive and anti-inflammatory agents have been tried for treatment although evidence remains limited.[38] In the chronic phase, surgical correction is reserved for fixed deformities like rocker bottom foot and persistent instability. In contrast, the cornerstone of DFO management is infection control through targeted antimicrobial therapy combined with surgical debridement or limited amputation in cases of gangrene or sepsis. Adequate wound care, off-loading, and revascularization in patients with peripheral arterial disease are essential to promote healing. Both CN and DFO require strict glycemic control, optimization of comorbidities, and a multidisciplinary approach involving the expertise of endocrinology, orthopedics, infectious disease, podiatry, vascular surgery, and radiology. In cases where both pathologies coexist, it is pertinent to integrate both therapeutic strategies and apply a case or patient-tailored approach.
The clinicoradiological approach to diabetic foot can be summarized in Graphical Abstract. The summary of the American College of Radiology (appropriateness criteria) for CN and DFO is as follows [Table 1][39,40]:
First-line imaging: Radiographs of the foot are recommended initially for all patients with suspected infection.
MRI with and without contrast is considered the most appropriate next test for suspected osteomyelitis or soft tissue infection, given its high sensitivity and specificity.
When MRI is inconclusive (i.e., unable to differentiate between sterile CN and DFO) or due to metallic hardware in the foot, labeled leukocyte scintigraphy (with or without SPECT/CT) of FDG/PET may be performed for detecting osteomyelitis.
MRI remains first-line for Charcot, but nuclear medicine is strongly advised in equivocal cases.
Monitoring Treatment Response: FDG-PET/CT and leukocyte scans may be used for assessing therapeutic response, but clinical and laboratory correlation remains essential.
| Features | Sterile Charcot neuropathy | Osteomyelitis |
|---|---|---|
| Radiographic features | Non-specific - fracture-dislocation, debris, joint subluxations | Periosteal elevation, loss of cortex with erosions, sequestrum (sclerotic dead bone), new bone formation (involucrum) |
| Periarticular fluid | + | ++ |
| Communicating sinus/abscess/cellulitis/ulcer | − | ++ |
| Site | Midfoot (Lisfranc and Chopart) | Forefoot |
| Pattern of spread | Polyarticular | Contiguous involvement |
| Subchondral changes | Edema, cysts | Disappearance of cysts |
| Ghost sign on T1 MRI | Absent | Present |
| Bony cortex | Preserved | Lost |
| Post-contrast imaging | Diffuse enhancement | Subarticular enhancement, peripheral enhancement in abscess/collections |
(+) denotes may be present, (-) denotes absent, (++) denotes almost always present. MRI: Magnetic resonance imaging
CONCLUSION
Both CN and DFO can present in a clinically identical manner, necessitating an imaging workup and differentiation between the two.
The key points that help to differentiate the two are detailed. Overall, regardless of the location, absence of communicating sinus/ulcer/abscess/cellulitis and reticular diffuse bone marrow edema favors neuroarthropathy. Disappearance of previously noted subchondral cysts, progressive bone marrow edema, and subarticular enhancement favor superimposed infection in a patient with background neuroarthropathy. In longstanding cases, the predominant imaging findings are subluxations, dislocations, bony deformities, subchondral cystic change, and bony debris with minimal to no marrow edema/effusion.
Accurate identification of superinfected neuropathic joints and differentiation of acute CN from DFO is the primary target of imaging studies advised in these patients. Noting the key hallmarks, bone marrow edema patterns, and area of involvement, while correlating with the clinical features, can help in improving the diagnostic accuracy and thus optimizing patient care. Current international recommendations emphasize MRI as the first-line modality for suspected diabetic foot complications, but nuclear imaging should be employed when MRI is non-diagnostic or contraindicated, or when differentiation between Charcot changes and infection is essential for patient management and for monitoring treatment response.
Ethical approval:
Institutional Review Board approval is not required.
Declaration of patient consent:
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given consent for clinical information to be reported in the journal. The patient understand that the patient’s names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Conflicts of interest:
Rajesh Botchu is on the Editorial Board of the Journal.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- Who was first to diagnose and report neuropathic arthropathy of the foot and ankle: Jean-Martin Charcot or Herbert William page? Diabetologia. 2013;56:1873-7.
- [CrossRef] [PubMed] [Google Scholar]
- Difference in presentation of Charcot osteoarthropathy in type 1 compared with type 2 diabetes. Diabetes Care. 2004;27:1235-6.
- [CrossRef] [PubMed] [Google Scholar]
- Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45:1085-96.
- [CrossRef] [PubMed] [Google Scholar]
- Charcot osteoarthropathy in diabetes: A brief review with an emphasis on clinical practice. World J Diabetes. 2011;2:59-65.
- [CrossRef] [PubMed] [Google Scholar]
- Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: Differences between Type 1 and Type 2 diabetes. Diabet Med. 2005;22:756-61.
- [CrossRef] [PubMed] [Google Scholar]
- Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon. J Foot Ankle Surg. 1997;36:272-8. discussion 330
- [CrossRef] [PubMed] [Google Scholar]
- An overview of Charcot's neuroarthropathy. J Clin Transl Endocrinol. 2020;22:100239.
- [CrossRef] [PubMed] [Google Scholar]
- Risk factors for developing osteomyelitis in patients with diabetic foot wounds. Diabetes Res Clin Pract. 2009;83:347-52.
- [CrossRef] [PubMed] [Google Scholar]
- The Charcot foot: A pictorial review. Insights Imaging. 2019;10:77.
- [CrossRef] [PubMed] [Google Scholar]
- Role of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections. J Vasc Surg. 1996;24:266-70.
- [CrossRef] [PubMed] [Google Scholar]
- Evaluation of the diabetic Charcot foot by MR imaging or plain radiography--an observational study. Exp Clin Endocrinol Diabetes. 2006;114:428-31.
- [CrossRef] [PubMed] [Google Scholar]
- Increased uptake of bone radiopharmaceutical in diabetic neuropathy. Q J Med. 1985;57:843-55.
- [Google Scholar]
- The role of bone scintigraphy with SPECT/CT in the characterization and early diagnosis of stage 0 charcot neuroarthropathy. J Clin Med. 2020;9:4123.
- [CrossRef] [PubMed] [Google Scholar]
- Combined bone scintigraphy and indium-111 leukocyte scans in neuropathic foot disease. J Nucl Med. 1988;29:1651-5.
- [Google Scholar]
- Tc-99m-HMPAO leukocyte scintigraphy for the diagnosis of osteomyelitis in diabetic foot infections. J Foot Ankle Surg. 1993;32:591-4.
- [Google Scholar]
- Preliminary evaluation of dual-energy CT to quantitatively assess bone marrow edema in patients with diabetic foot ulcers and suspected osteomyelitis. Eur Radiol. 2023;33:5645-52.
- [CrossRef] [PubMed] [Google Scholar]
- Osteomyelitis or Charcot neuro-osteoarthropathy? Differentiating these disorders in diabetic patients with a foot problem. Diabet Foot Ankle. 2013;4:21855.
- [CrossRef] [PubMed] [Google Scholar]
- 2012 infectious diseases society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54:e132-73.
- [CrossRef] [PubMed] [Google Scholar]
- Charcot foot in diabetes and an update on imaging. Diabet Foot Ankle. 2013;4:21884.
- [CrossRef] [PubMed] [Google Scholar]
- The Charcot foot: Pathophysiology, diagnosis and classification. Bone Joint J. 2016;98:1155-9.
- [CrossRef] [PubMed] [Google Scholar]
- Radiological assessment of Charcot neuro-osteoarthropathy in diabetic foot: A narrative review. Diagnostics (Basel). 2025;15:767.
- [CrossRef] [PubMed] [Google Scholar]
- Diabetic neuroarthropathy in the foot: Patient characteristics and patterns of radiographic change. Foot Ankle. 1983;4:15-22.
- [CrossRef] [PubMed] [Google Scholar]
- Assessment of bone marrow edema on dual-energy CT scans in people with diabetes mellitus and suspected Charcot neuro-osteoarthropathy. Skeletal Radiol. 2025;54:105-12.
- [CrossRef] [PubMed] [Google Scholar]
- MRI evaluation of bone marrow changes in the diabetic foot: A practical approach. Semin Musculoskelet Radiol. 2011;15:257-68.
- [CrossRef] [PubMed] [Google Scholar]
- Differential diagnosis of pedal osteomyelitis and diabetic neuroarthropathy: MR Imaging. Semin Musculoskelet Radiol. 2005;9:272-83.
- [CrossRef] [PubMed] [Google Scholar]
- Use of MR imaging in diagnosing diabetes-related pedal osteomyelitis. Radiographics. 2010;30:723-36.
- [CrossRef] [PubMed] [Google Scholar]
- Magnetic resonance imaging in early stage Charcot arthropathy: Correlation of imaging findings and clinical symptoms. Eur J Med Res. 2008;13:409-14.
- [Google Scholar]
- Relationship of foot deformity to ulcer location in patients with diabetes mellitus. Phys Ther. 1990;70:356-62.
- [CrossRef] [PubMed] [Google Scholar]
- T1-weighted MRI characteristics of pedal osteomyelitis. AJR Am J Roentgenol. 2005;185:386-93.
- [CrossRef] [PubMed] [Google Scholar]
- MRI of the diabetic foot: Differentiation of infection from neuropathic change. Br J Radiol. 2007;80:939-48.
- [CrossRef] [PubMed] [Google Scholar]
- How to do and evaluate DWI and DCE-MRI sequences for diabetic foot assessment. Skeletal Radiol. 2024;53:1979-90.
- [CrossRef] [PubMed] [Google Scholar]
- Ghost sign on diffusion-weighted imaging generated apparent diffusion coefficient map: Additional MRI diagnostic marker for extremity osteomyelitis. Indian J Radiol Imaging. 2024;35:81-7.
- [CrossRef] [PubMed] [Google Scholar]
- The utility of chemical shift imaging and related Dixon images in evaluation of bone marrow edema-like changes in diabetic foot. Egypt J Radiol Nucl Med. 2023;54:76.
- [CrossRef] [Google Scholar]
- Diagnostic imaging of the diabetic foot: An EANM evidence-based guidance. Eur J Nucl Med Mol Imaging. 2024;51:2229-46.
- [CrossRef] [PubMed] [Google Scholar]
- EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med. 2013;54:647-58.
- [CrossRef] [PubMed] [Google Scholar]
- Efficacy of medical treatment for Charcot neuroarthropathy: A systematic review and meta-analysis of randomized controlled trials. Acta Diabetol. 2021;58:687-96.
- [CrossRef] [PubMed] [Google Scholar]
- ACR appropriateness criteria® suspected osteomyelitis of the foot in patients with diabetes mellitus. J Am Coll Radiol. 2019;16:S440-50.
- [CrossRef] [PubMed] [Google Scholar]
- Neuropathic arthropathy of the foot with and without superimposed osteomyelitis: MR imaging characteristics. Radiology. 2006;238:622-31.
- [CrossRef] [PubMed] [Google Scholar]


